DE69708425D1 - Makrophagen infizierende Parasiten, die ein Leukozyten- und Makrophagen-stimulierendes Hormon exprimieren - Google Patents

Makrophagen infizierende Parasiten, die ein Leukozyten- und Makrophagen-stimulierendes Hormon exprimieren

Info

Publication number
DE69708425D1
DE69708425D1 DE69708425T DE69708425T DE69708425D1 DE 69708425 D1 DE69708425 D1 DE 69708425D1 DE 69708425 T DE69708425 T DE 69708425T DE 69708425 T DE69708425 T DE 69708425T DE 69708425 D1 DE69708425 D1 DE 69708425D1
Authority
DE
Germany
Prior art keywords
macrophage
parasites
express
leishmania
leukocyte
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69708425T
Other languages
English (en)
Other versions
DE69708425T2 (de
Inventor
Barbara Papadopoulou
Marc Ouellette
Martin Olivier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universite Laval
Original Assignee
Universite Laval
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universite Laval filed Critical Universite Laval
Application granted granted Critical
Publication of DE69708425D1 publication Critical patent/DE69708425D1/de
Publication of DE69708425T2 publication Critical patent/DE69708425T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE69708425T 1996-09-13 1997-09-12 Makrophagen infizierende Parasiten, die ein Leukozyten- und Makrophagen-stimulierendes Hormon exprimieren Expired - Lifetime DE69708425T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/713,768 US6331304B1 (en) 1996-09-13 1996-09-13 Macrophage-infecting parasites expressing a granulocyte macrophage colony stimulating factor

Publications (2)

Publication Number Publication Date
DE69708425D1 true DE69708425D1 (de) 2002-01-03
DE69708425T2 DE69708425T2 (de) 2002-05-23

Family

ID=24867467

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69708425T Expired - Lifetime DE69708425T2 (de) 1996-09-13 1997-09-12 Makrophagen infizierende Parasiten, die ein Leukozyten- und Makrophagen-stimulierendes Hormon exprimieren

Country Status (8)

Country Link
US (1) US6331304B1 (de)
EP (1) EP0829540B1 (de)
AT (1) ATE209253T1 (de)
CA (1) CA2215641C (de)
DE (1) DE69708425T2 (de)
DK (1) DK0829540T3 (de)
ES (1) ES2168583T3 (de)
PT (1) PT829540E (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6855537B1 (en) * 1996-09-13 2005-02-15 Aventis Pasteur Limited Macrophage-infecting parasites expressing a granulocyte macrophage colony stimulated factor
GB9706930D0 (en) * 1997-04-04 1997-05-21 Univ Glasgow Leishmania vaccine
US6368827B1 (en) * 1998-12-02 2002-04-09 The University Of Georgia Research Foundation, Inc. Kinetoplastid protein expression system and methods
US20010010928A1 (en) * 1999-03-26 2001-08-02 Stephen M. Beverley Protozoan expression system
WO2002090556A1 (en) * 2001-05-08 2002-11-14 Jena Bioscience Gmbh Method for targeted homologous gene replacement in kinetoplastidae

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE236252T1 (de) * 1993-09-03 2003-04-15 Univ Mcgill Differentiell exprimierte leishmania gene und proteinen

Also Published As

Publication number Publication date
EP0829540B1 (de) 2001-11-21
EP0829540A1 (de) 1998-03-18
ATE209253T1 (de) 2001-12-15
CA2215641C (en) 2009-07-07
DE69708425T2 (de) 2002-05-23
DK0829540T3 (da) 2002-05-21
PT829540E (pt) 2002-05-31
CA2215641A1 (en) 1998-03-13
ES2168583T3 (es) 2002-06-16
US6331304B1 (en) 2001-12-18

Similar Documents

Publication Publication Date Title
ES2176232T3 (es) Vacuna adecuada para ser utilizada en la prevencion y tratamiento de la infeccion por helicobacter.
WO2001068077A3 (en) Immunostimulatory polynucleotide sequences for use in preventing and treating viral infections
GR3035458T3 (en) Composition comprising a recombinant virus expressing an antigen and a recombinant virus expressing an immunostimulatory molecule
ATE306938T1 (de) Verwendung von cpg als adjuvans für hivimpstoff
AU7242796A (en) Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
MX2022010373A (es) Vacuna contra el virus de la peste porcina africana.
DE69708425D1 (de) Makrophagen infizierende Parasiten, die ein Leukozyten- und Makrophagen-stimulierendes Hormon exprimieren
GR3022248T3 (en) Oligonucleotide sequences for amplification of type HIV-2 and SIV retroviruses genomes and their application to in-vitro diagnostic of infections caused by these viruses
IL123264A0 (en) Multi-subtype FIV vaccines
MXPA02010173A (es) Antigenos de leishmania para utilizarse en la terapia y el diagnostico de leishmaniasis.
DE69510858D1 (de) Mukosale Verabreichung von Pneumokokken-Antigenen
DE3579617D1 (de) Lebender gereinigter impfstoff gegen die marek'sche krankheit.
EP0806476A3 (de) Abgeschwächter Stamm von Leishmania und dessen Verwendung
CA2243730A1 (en) Streptococcus equi vaccine
PT642796E (pt) Vacina viva de salmonella
WO1998035045A3 (en) Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
WO2003032917A3 (en) Hookworm vaccine
ES2162862T3 (es) Uso de la timosina para tratar la hepatitis c en pacientes que no responden al tratamiento con interferon.
HUP9700975A2 (hu) Élő, legyengített, Pasteurellaceae családba tartozó, RTX-termelő baktériumok
Klein et al. Protection against establishment of latent infections in mice immunized with a non-pathogenic herpes simplex virus mutant and reinfected with the pathogenic parental strain
Michaeli Smallpox: a possible comeback
EP1422238A3 (de) Leishmania Antigene für Verwendung in der Therapie und Diagnose von Leishmaniose

Legal Events

Date Code Title Description
8364 No opposition during term of opposition